4Bigazzi R, Bianchi S, Campese VM, et al. Prevalence of microalbuminuria in a large population of patients with mild to moderate essential hypertension [J]. Nephron, 1992 ;61:94-7.
4Chalmers J, MacMahon S, Mancia G, et al. 1999 world health organization-International society of hypertension guidelines for the management of hypertension. Guidelines sub-committee of the World Health Organization[J].Clin Exp Hypertens, 1999,21(5-6):1009-1060.
6Krum H,Viskoper RJ.Lacourciere Y,et al.The effect of an endothelin-receptor antagonist,bosentan,on blood pressure in patients with essential hypertension.Bosentan Hypertension Investigatiors.N Eng J Med,1998,338(12):784-790.
7Maeso R,Rodrigo E,Munoz-Garcia R,et al.Factors involved in the effects of losarton on endothelial dysfunction induced by aging in SHR.Kidney Int Suppl,1998,68:S30-35.
8沈来龙．高血压病患者尿微量蛋白检测及其临床意义B151．全国心血病学术会议，2000．
9Hiratsuka N, Shiba K, Nishide K, et al. Analysis of urinary albumin, transferring, N- acetylbeta - D - glucosaminidase and beta 2- microglobulin in patients with impaired glucose tolerance. J Clin Lab Anal, 1998,12(6) :351 - 353.
10Grundy SM. Consensus statement:Role of therapy with“statins” in patients with hypertriglyceridemia. Am J Cardiol, 1998, 81 (4A) : 1B - 6B.
